Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| squamous epithelial cell | 3 studies | 31% ± 17% | |
| epithelial cell | 3 studies | 41% ± 17% | |
| retinal cone cell | 3 studies | 41% ± 14% | |
| endothelial cell | 3 studies | 24% ± 11% |
Insufficient scRNA-seq data for expression of LRATD2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 2638.51 | 459 / 459 | 99% | 88.99 | 1104 / 1118 |
| prostate | 100% | 1691.67 | 245 / 245 | 98% | 40.58 | 494 / 502 |
| pancreas | 100% | 1701.01 | 328 / 328 | 96% | 32.16 | 171 / 178 |
| kidney | 100% | 4421.58 | 89 / 89 | 96% | 48.45 | 863 / 901 |
| lung | 99% | 2368.73 | 575 / 578 | 95% | 43.44 | 1103 / 1155 |
| stomach | 97% | 2360.63 | 347 / 359 | 95% | 50.11 | 271 / 286 |
| brain | 96% | 903.65 | 2524 / 2642 | 96% | 63.49 | 674 / 705 |
| bladder | 100% | 1130.24 | 21 / 21 | 91% | 30.58 | 458 / 504 |
| intestine | 93% | 1059.50 | 901 / 966 | 97% | 40.74 | 513 / 527 |
| esophagus | 96% | 2242.55 | 1388 / 1445 | 95% | 37.88 | 173 / 183 |
| thymus | 100% | 1560.64 | 652 / 653 | 90% | 32.29 | 543 / 605 |
| ovary | 89% | 576.95 | 161 / 180 | 98% | 43.30 | 423 / 430 |
| uterus | 98% | 1862.38 | 167 / 170 | 81% | 21.91 | 372 / 459 |
| liver | 100% | 1247.20 | 226 / 226 | 63% | 14.36 | 255 / 406 |
| skin | 73% | 1364.61 | 1314 / 1809 | 56% | 26.31 | 263 / 472 |
| adrenal gland | 91% | 634.41 | 236 / 258 | 12% | 2.25 | 28 / 230 |
| ureter | 0% | 0 | 0 / 0 | 100% | 31.76 | 1 / 1 |
| adipose | 100% | 1726.80 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 97% | 625.56 | 233 / 241 | 0% | 0 | 0 / 0 |
| heart | 89% | 670.07 | 762 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 82% | 18.66 | 37 / 45 |
| blood vessel | 61% | 365.24 | 813 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 36% | 6.29 | 29 / 80 |
| muscle | 33% | 135.75 | 264 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 7% | 30.85 | 64 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | LRATD2 |
| Protein name | Protein LRATD2 (Breast cancer membrane protein 101) (LRAT domain-containing 2) (Protein FAM84B) (Protein NSE2) |
| Synonyms | NSE2 FAM84B BCMP101 |
| Description | |
| Accessions | Q96KN1 ENST00000304916.4 ENST00000652209.1 |